No Double Duty For Von Eschenbach; Niederhuber To Run NCI
This article was originally published in The Pink Sheet Daily
Executive Summary
John Niederhuber, recently tapped to be NCI deputy director for translational and clinical sciences, will assume the position of chief operating officer, handling day-to-day management of the cancer institute.
You may also be interested in...
FDA Must Maintain Conflict of Interest Waivers, Gottlieb Argues
The inability to issue conflict of interest waivers would diminish advisory panels’ importance to the agency, the Deputy Commissioner for Medical & Scientific Affairs said at an event on government panels.
FDA Must Maintain Conflict of Interest Waivers, Gottlieb Argues
The inability to issue conflict of interest waivers would diminish advisory panels’ importance to the agency, the Deputy Commissioner for Medical & Scientific Affairs said at an event on government panels.
Von Eschenbach’s Recusal Does Not Eliminate Conflicts, Democrats Say
In letter to Secretary Leavitt, three ranking house members denounce the acting commissioner’s promise of non-involvement in FDA decisions regarding the National Cancer Institute.